Impact of 6-month triptorelin formulation on predicted adult height and basal gonadotropin levels in patients with central precocious puberty

Impact of 6-month triptorelin formulation on predicted adult height and basal gonadotropin levels in patients with central precocious puberty

BackgroundTriptorelin, a long-acting gonadotropin-releasing hormone (GnRH) agonist, is available in 1-, 3-, and 6-month formulations to treat central precocious puberty (CPP). The triptorelin pamoate 22.5-mg 6-month formulation recently approved for CPP offers greater convenience to children by redu...

Full description

Bibliographic Details
Main Authors: Eunjoo Yoo, Sinae Kim, Hye Lim Jung, Jung Yeon Shim, Jae Won Shim, Deok Soo Kim, Ji Hee Kwak, Eun Sil Kim, Aram Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Endocrinology
Subjects:
central precocious puberty
gonadotrophin-releasing hormone analogue
gonadotropins
triptorelin pamoate
6-month formulation
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1134977/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1134977/full

Similar Items